Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,359 | 3,076 | 3,055 | 5,160 | 3,959 |
| Marketable Securities | 7,954 | 10,075 | 11,563 | 12,037 | 7,293 |
| TOTAL | $14,674 | $13,975 | $15,623 | $18,310 | $12,162 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 479 | 561 | 694 | 239 | 595 |
| TOTAL | $479 | $561 | $694 | $239 | $595 |
| Total Assets | $15,153 | $14,536 | $16,318 | $18,549 | $12,757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,270 | 2,826 | 2,383 | N/A |
| Accounts payable and accrued liabilities | 1,727 | 1,204 | 881 | 1,206 | 1,172 |
| Accrued Expenses | N/A | 35 | 23 | 11 | N/A |
| Other current liabilities | N/A | 731 | 1,351 | 1,287 | N/A |
| TOTAL | $3,382 | $6,477 | $6,078 | $5,739 | $1,918 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,214 | 0 | 0 | 0 | 5,041 |
| TOTAL | $4,224 | $16 | $21 | $25 | $5,069 |
| Total Liabilities | $7,607 | $6,493 | $6,098 | $5,764 | $6,987 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,925 | 23,825 | 20,170 | 19,278 | 19,269 |
| Retained earnings | -65,499 | -60,277 | -56,633 | -52,825 | -49,132 |
| Other shareholders' equity | -7 | -7 | -6 | -7 | 0 |
| TOTAL | $7,546 | $8,043 | $10,220 | $12,786 | $5,770 |
| Total Liabilities And Equity | $15,153 | $14,536 | $16,318 | $18,549 | $12,757 |